RLX Technology's third quarter marked a pivotal step in its transformation from a China-focused e-vapor maker into a global branded platform. After completing a mid-year European distribution acquisition, this was the first full quarter to consolidate that business, making it a key test of whether the company could scale revenue without sacrificing profitability. The results matter because they reveal how quickly international expansion is translating into the top line, how acquisition costs and currency swings are reshaping margins, and how effectively management is preserving cash returns. With international markets now driving the vast majority of revenue, I am watching closely to see whether growth momentum can offset the margin compression tied to a lower-margin distribution model.
RLX Technology reported net revenues of RMB 1.92 billion for the third quarter ended September 30, 2026, up 69.7% from RMB 1.13 billion in the prior-year period. Net income attributable to RLX was RMB 160.7 million, down from RMB 203.2 million a year earlier, while diluted EPS from continuing operations came in at RMB 0.123 versus RMB 0.157. Adjusted (non-GAAP) net income was RMB 227.5 million, or RMB 0.175 per share, compared with RMB 286.3 million, or RMB 0.221 per share, in the prior-year quarter.
Gross margin declined to 23.3% from 31.2%, driven by the consolidation of the acquired European distribution business and a one-time non-cash inventory fair-value step-up of RMB 43.5 million tied to the acquisition. Operating expenses widened to RMB 407.1 million from RMB 259.3 million, led by higher general and administrative, logistics, and consulting costs. On a non-GAAP basis, operating income was RMB 143.8 million and net income reached RMB 235.6 million, while net cash from operating activities rebounded to a positive RMB 40.0 million. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
RLX shares traded modestly lower in pre-market activity following the report, as investors weighed record revenue growth against declining profitability and a narrowing gross margin. Sentiment heading into the print had been cautious, with the stock having underperformed over the trailing three- and twelve-month periods amid regulatory uncertainty and integration costs tied to the European acquisition. The earnings narrative centered on two opposing forces: a 69.7% revenue surge that confirmed global demand strength, and margin compression that reflected a structural shift toward lower-margin distribution revenue, plus foreign-exchange translation headwinds as the Chinese renminbi (RMB) appreciated against the currencies in which overseas sales are denominated.
Management pointed to several themes that will shape the coming quarters. First, the integration of the European acquisition is expected to drive meaningful margin expansion next year as existing inventory cycles through and operational synergies take hold. Investors should monitor whether gross margin recovers toward the non-GAAP level of roughly 25% or higher that management cited once the one-time inventory step-up is excluded.
Second, regulatory transitions remain a central watch item. The United Kingdom's introduction of a vaping excise duty in October is expected to create transitional working capital absorption, while China's cancellation of value-added tax (VAT) rebates for vapor manufacturers introduces potential margin pressure. Management indicated the inventory pull-forward related to these policy shifts concluded cleanly in the third quarter, providing a cleaner operating baseline for 2027.
Finally, capital allocation will stay in focus. RLX Technology reiterated a commitment to return at least 100% of non-GAAP net income annually through dividends and share repurchases, with the board set to evaluate a dividend in the first half of next year. With total financial assets of roughly RMB 13.48 billion, the balance sheet provides flexibility for both shareholder returns and continued merger and acquisition (M&A) activity across Europe.
In my view, tools like Tickeron's AI-powered platforms can add useful perspective when reviewing earnings releases such as this one. The AI Screener, for instance, allows filtering by technical patterns, fundamentals, and performance metrics to identify comparable opportunities across the market. From what I see, it helps surface ideas that align with specific criteria without replacing traditional fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RLX declined for three days, in 201 of 253 cases, the price declined further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RLX as a result. In 72 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for RLX turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 42 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
The Aroon Indicator for RLX entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where RLX advanced for three days, in 140 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
RLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.127) is normal, around the industry mean (-7.297). P/E Ratio (2.155) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.595). RLX's Dividend Yield (0.248) is considerably higher than the industry average of (0.060). P/S Ratio (3.162) is also within normal values, averaging (2.780).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. RLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Tobacco